Medical device and MedTech insights, news, tips and more

Orchid Orthopedic Solutions Acquired by European Private Equity Firm

January 23, 2019


Nordic Capital Fund IX announced today that it has agreed to acquire a majority holding in Orchid Orthopedic Solutions, from Altor Fund III who will retain a significant minority holding in the company.

Headquartered in Holt, Michigan, Orchid is a world leader in the design and manufacture of implants to the global orthopedic market. Orchid’s leading offerings span hip, knee, trauma, extremity and spinal implant products, as well as single-use and multi-use complex instruments used in implant related surgical procedures.

As a strategic partner to the leading global medical device OEMs, Orchid offers solutions in product and procedure design and possesses the full range of manufacturing processes required to produce finished, packaged products. The company serves a global customer base from its 12 manufacturing sites in the U.S., UK, Switzerland and China. Orchid innovates continually to provide differentiated processes yielding unique products, while simplifying its customers’ supply chains, delivering outstanding quality and offering end-to-end solutions benefiting from the broadest implants portfolio in the market.

The orthopedic implant market benefits from strong secular growth driven by larger and increasingly active elderly populations, obesity, medical advancements and increased access to surgical orthopaedic care. As a leader in the industry and with Nordic Capital’s support, Orchid is ideally positioned to capitalise on this demand growth while helping its customers become more competitive.

“We are impressed by Orchid’s strong management team and attractive position in the growing orthopaedic implant market, and look forward to supporting the company through its next phase of development. Orchid has a unique set of implant manufacturing capabilities across product categories, and is a true innovator simplifying and improving its customers’ supply chains. We are fully committed to supporting Orchid’s growth strategy in close partnership with management,” says Jonas Agnblad, Partner and Co-head of Healthcare at the advisor to the Nordic Capital Funds.

Orchid’s current management team, led by CEO Jerry Jurkiewicz, will continue to lead the company, building on its strong track record of both organic and acquisitive growth.

“We are very proud of our achievements during Altor’s tenure as our majority owner and are very excited to continue this journey with Nordic Capital as our new majority partner. We have transformed Orchid from a U.S. contract manufacturer to the leading global orthopedic implants design and manufacturing partner in the world. We will continue to build out the Orchid platform with a focus on satisfying customers with our broad array of innovative implants procedure solutions from a global network of operationally excellent sites. With a great additional partner like Nordic Capital, I am confident our progress will accelerate” says Orchid CEO Jerry Jurkiewicz.

Nordic Capital is the pre-eminent European healthcare investor with a strong track-record of successful healthcare investments in North America. Since inception in 1989 the Nordic Capital Funds have deployed more than EUR 6 billion in 27 healthcare platform investments across Europe and North America, supporting active value creation agendas to build industry winners.

Altor has been the majority owner of Orchid since 2011 and agreed to divest the majority of its current holding while retaining a significant minority holding in the company.

Read More at the Source: Nordic Capital Acquires Orchid Orthopedic Solutions

Press Release by Nordic Capital & Orchid Orthopedic

A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.


More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.